Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 0.7232 0.0025 (0.35%) Market Cap: 185.06 Mil Enterprise Value: 72.82 Mil PE Ratio: 0 PB Ratio: 2.33 GF Score: 63/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1